Sarepta Therapeutics (SRPT) Change in Account Payables (2025 - 2026)
Sarepta Therapeutics' (SRPT) quarterly Change in Account Payables came in at -$210.5 million in Q1 2026, down 260.77% year-on-year from $130.9 million in Q1 2025, and down 260.77% quarter-over-quarter from -$58.3 million in Q1 2025.
Sarepta Therapeutics (SRPT) Change in Account Payables (2025 - 2026) Analysis & Trends
Sarepta Therapeutics' Change in Account Payables history runs 2 years deep, the most recent figure standing at -$210.5 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Sarepta Therapeutics | 1.69 Bn | 1.28 Bn | 622.04 Mn | -210.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -210.47 Mn |
| Mar 31, 2026 | -210.47 Mn |
| Mar 31, 2025 | -58.34 Mn |
| Mar 31, 2025 | -58.34 Mn |